20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is LURASIDONE HYDROCHLORIDE, with a corresponding US DMF Number 28252.
Remarkably, this DMF maintains an Active status since its submission on June 04, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2014, and payment made on May 30, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II